Pressroom: Media Coverage

Showing 461 - 480 of 656 news items


When Supplements Become Dangerous

Herbalist and manager of Memorial Sloan Kettering’s About Herbs database K. Simon Yeung spoke about using dietary supplements to ease side effects of cancer treatment. He said that while some herbs help alleviate symptoms many can pose risks for people with cancer.

April 4, 2012
Interrupting Cancer's Travel Plans

Cancer Biology and Genetics Program Chair Joan Massagué discussed cancer metastasis. He said that while the silent nature of metastasis makes it a particularly daunting research subject, he’s optimistic that current research will yield treatments that extend patients’ lives.

April 1, 2012
Alec Guinness, Reluctant Intergalactic Icon

Medical oncologist Ghassan Abou-Alfa spoke about efforts to prevent and treat liver cancer 12 years after actor Alec Guinness’s death. He said that while liver cancer remains a frustrating disease, the past two decades have seen the emergence of new treatments. While only modestly successful, they do suggest a new approach to therapy.

April 1, 2012
Facing Your Challenges

Head and Neck Oncology Service Chief David Pfister spoke about quality of life after head and neck cancer. He said, “We are no longer satisfied with just cure and survival. We want to provide patients with optimal treatment to ‘beat’ their cancer while minimizing the side effects, both short and long term, from their therapy.”

April 1, 2012
Long-Term Estrogen Therapy Does Up Breast Cancer Risk

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton commented on a study that found that using estrogen-only hormone replacement therapy for ten years or more increases the long-term risk for breast cancer. Dr. Norton said he does not recommend that women take estrogen after menopause because “the jury is still out on how safe estrogen alone is.”

April 1, 2012
New Scanning Technology Might Help Guide Prostate Cancer Care

Memorial Sloan Kettering researcher Michael Evans reported on a new way to measure PSA, or prostate-specific antigen, a protein produced by cells of the prostate gland that can be an indication of prostate cancer. The new tool could provide a more accurate way to stage or monitor prostate cancer when compared with standard PSA screening tests.

March 31, 2012
HPV Vaccine May Prevent Recurrence of Precancerous Conditions

Gynecologic oncologist Ginger Gardner commented on a recent study that found that the HPV vaccine, in addition to preventing cervical cancer, may also prevent women diagnosed with precancerous conditions from developing recurrences. Dr. Gardner said the study is encouraging because there is currently no way to prevent the recurrence of these conditions, meaning clinicians must continually monitor them.

March 28, 2012
Breast Cancer Hot Topic: Clear Tumor Margins

Many women who have lumpectomies must have a re-operation in order to achieve cancer-free margins around the surgically removed tumor, but there is debate in the medical community as to what constitutes a clear margin. Breast Surgical Service Chief Monica Morrow suggested research could be better directed toward identifying factors that cause early-stage breast cancer to become invasive, which she believes is critical to tailoring treatment.

March 26, 2012
How Much Aspirin Is Too Much of a Good Thing?

Breast Cancer Medicine Service Chief Clifford Hudis commented on recent studies that suggest that daily aspirin use may reduce the risk of several cancers and stop the spread of tumors. He said that while the data with regard to breast cancer is interesting, it is not actionable.

March 26, 2012
How Collaboration Between IBM and Memorial Sloan Kettering Taps the Wisdom of Physicians

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton authored this post about the new MSKCC-IBM collaboration to develop a decision-support tool based upon IBM’s Watson computer. He said, “The human is never left out of the conversation. And that humanity—never before captured in guidelines or lists of therapeutic options—is what makes this project unique: It goes beyond mere knowledge, as important as that is, by entering the realm of human wisdom.”

March 23, 2012
IBM’s Watson to Help Memorial Sloan Kettering with Cancer

Memorial Sloan Kettering and IBM announced they will collaborate on the development of a powerful new tool built upon IBM’s Watson computer. Memorial Sloan Kettering will “teach” the computer to review case histories so oncologists located anywhere will have the ability to obtain detailed diagnostic and treatment options based on the latest research. Memorial Sloan Kettering President and CEO Craig Thompson said it has the potential to revolutionize the accessibility of information.

March 22, 2012
IBM Watson Hits Daily Double Fighting Cancer with Memorial Sloan Kettering

Thoracic Oncology Service Chief Mark Kris said the new MSKCC-IBM collaboration to develop a supercomputer to support oncologists is “like having a Memorial Sloan Kettering trained colleague for any doctor on earth.” Built upon IBM’s Watson computer, the new tool will combine Watson’s advanced analytics capabilities with Memorial Sloan Kettering’s clinical insights.

March 22, 2012
Could Graphic New Anti Smoking Ads Do More Harm?

Infectious disease specialist Kent Sepkowitz authored this essay about the CDC’s new campaign of graphic anti-smoking ads. He discussed the use of fear to promote a change in behavior and said, “The scarier the message, the stronger the effect.”

March 16, 2012
Leukemia Gene Mutations Linked to Survival Odds

Physician-scientist Ross Levine discussed his study that found that a mutation in the gene known as TET2 contributes to the development of some leukemias. The discovery provides a key insight into what first goes wrong in the development of many leukemias and shows that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets.

March 15, 2012
Finding Reliable Cancer Information Online

Integrative Medicine Service Chief Barrie Cassileth talked about the dangers of exploring treatment options online, especially herbal remedies touted as cancer therapies because many consumers don’t realize that these may interfere with chemotherapy and prescription medications. She suggested visiting Memorial Sloan Kettering’s About Herbs database, which provides evidence-based information on more than 250 herbs, botanicals, and supplements.

March 14, 2012
Advances in Bladder Cancer Treatment Around the Corner

Urologic surgeon Harry Herr talked about current treatment options for bladder cancer and the research under way to bring new treatments to patients.

March 14, 2012
Pursuing an Ethic of Service: Lung Cancer Researcher Noted for Drug Discovery, Charitable Works

In this profile piece, Thoracic Oncology Service Chief Mark Kris discussed his career, current research interests, and charitable work. He said, “I’ve heard people say that, if you choose the right profession or job, you’ll never have to work a day in your life, and I feel like that.”

March 13, 2012
Many with Cancer Pain Aren't on Strong Painkillers

Pain and Palliative Care Service Chief Paul Glare commented on a study that found that one in three older cancer patients are not taking opioids to treat their pain. Dr. Glare said that if patients feel their pain is not being addressed by their doctor, they should ask to see a pain specialist for treatment.

March 9, 2012
Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug

Medical oncologist Jedd Wolchok discussed a unique single-patient study that demonstrates a rare phenomenon called the abscopal effect, in which radiation to just one tumor causes other tumors all over the body to regress. The patient studied took ipilimumab (Yervoy™), a drug that stimulates the immune system to fight cancer cells, but did not respond to the medicine until she got a radiation treatment.

March 8, 2012
New Treatment Successfully Targets Tumors

Medical oncologist Jedd Wolchok and his patient Valerie Esposito spoke about the rare medical phenomenon she experienced when local radiation to just one tumor caused other tumors in her body to shrink. Dr. Wolchok said, “We’re very excited about this result because we treated just one tumor with radiation therapy in this patient, and as a result, distant tumors regressed.”

March 7, 2012